17-alpha-hydroxyprogesterone and orlistat

17-alpha-hydroxyprogesterone has been researched along with orlistat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Farmakiotis, D; Katsikis, I; Kourtis, A; Krassas, G; Panidis, D; Rousso, D	1

Trials

1 trial(s) available for 17-alpha-hydroxyprogesterone and orlistat

Article	Year
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Fertility and sterility, 2008, Volume: 89, Issue:4 Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Anti-Obesity Agents; Blood Glucose; Body Mass Index; Caloric Restriction; Case-Control Studies; Combined Modality Therapy; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Lactones; Luteinizing Hormone; Obesity; Orlistat; Polycystic Ovary Syndrome; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Weight Loss	2008

Article

Year

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.

Fertility and sterility, 2008, Volume: 89, Issue:4

Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Anti-Obesity Agents; Blood Glucose; Body Mass Index; Caloric Restriction; Case-Control Studies; Combined Modality Therapy; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Lactones; Luteinizing Hormone; Obesity; Orlistat; Polycystic Ovary Syndrome; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Weight Loss

2008